SciVision Biotech Dividenden en inkoop
Dividend criteriumcontroles 3/6
SciVision Biotech is een dividendbetalend bedrijf met een huidig rendement van 2.68% dat ruimschoots wordt gedekt door de winst.
Belangrijke informatie
2.7%
Dividendrendement
n/a
Terugkoop Rendement
Totaal aandeelhoudersrendement | n/a |
Toekomstig dividendrendement | n/a |
Dividendgroei | 13.5% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | NT$2.500 |
Uitbetalingsratio | 79% |
Recente updates van dividend en inkoop
SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50
Jun 28Recent updates
Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?
Oct 11SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings
Aug 30SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50
Jun 28SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings
Jun 14SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly
Jun 04Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio
Apr 01Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Apr 20SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital
Apr 02Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?
Mar 15Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend
Feb 25Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?
Feb 05Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly
Jan 18Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?
Jan 01SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years
Dec 14Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend
Nov 25Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 1786 betaalt al minder dan 10 jaar dividend en gedurende deze periode zijn de betalingen volatiel geweest.
Groeiend dividend: De dividendbetalingen van 1786 zijn gestegen, maar het bedrijf heeft pas 9 jaar dividend uitgekeerd.
Dividendrendement versus markt
SciVision Biotech Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (1786) | 2.7% |
Markt onderkant 25% (TW) | 1.7% |
Markt Top 25% (TW) | 4.5% |
Gemiddelde industrie (Medical Equipment) | 2.9% |
Analist prognose (1786) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Het dividend van 1786 ( 2.68% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de TW markt ( 1.73% ).
Hoog dividend: Het dividend 1786 ( 2.68% ) is laag vergeleken met de top 25% van dividendbetalers in de TW markt ( 4.45% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Bij de huidige payout ratio ( 79% ) worden de betalingen van 1786 gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Op basis van de huidige cash payout ratio ( 78.8% ) worden de dividendbetalingen van 1786 gedekt door kasstromen.